OTC Class I/II recalls would require in-store patient notification under Shays/Dodd bill.
This article was originally published in The Tan Sheet
Executive Summary
OTC RECALL IN-STORE NOTIFICATION WOULD BE REQUIRED UNDER SHAYS/DODD BILL for Class I and Class II recalls involving all over-the-counter drug products sold in pharmacies. Retail outlets that only sell OTC products also could be required to display recall notices under the bill. The measure would require pharmacies to notify patients in writing when a prescription drug or device they purchased is subject to a Class I or Class II recall.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning